Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Guide to Mechanical Circulatory SupportPatient Optimization Prior to MCS

A Guide to Mechanical Circulatory Support: Patient Optimization Prior to MCS [Comorbidities are chronic conditions that co-exist with a primary diagnosis of interest. It is often understood that many patients with advanced heart failure frequently have more than one major chronic comorbid condition which are often associated with increased health utilization and increased mortality (Iorio et al., Eur J Heart Fail 20:1257–66, 2018; Koen et al., Int J Cardiol 271:132–9, 2018). Comorbidities are not necessarily a contraindication to LVAD therapy; however, they may impact the postoperative recovery phase, including mobility and wound healing. Prior to LVAD implant, patients must have all major comorbid conditions optimized for successful outcome. This includes but not limited to ensuring optimal end-organ function, glycemic control, elimination of infection, and mental readiness of both patient and caregiver. This chapter provides guidelines and considerations for optimization before LVAD implantation.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Guide to Mechanical Circulatory SupportPatient Optimization Prior to MCS

Editors: Stewart, Scott; Blood, Peggy

Loading next page...
 
/lp/springer-journals/a-guide-to-mechanical-circulatory-support-patient-optimization-prior-Y34zBFfb0e
Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
ISBN
978-3-031-05712-0
Pages
39 –55
DOI
10.1007/978-3-031-05713-7_4
Publisher site
See Chapter on Publisher Site

Abstract

[Comorbidities are chronic conditions that co-exist with a primary diagnosis of interest. It is often understood that many patients with advanced heart failure frequently have more than one major chronic comorbid condition which are often associated with increased health utilization and increased mortality (Iorio et al., Eur J Heart Fail 20:1257–66, 2018; Koen et al., Int J Cardiol 271:132–9, 2018). Comorbidities are not necessarily a contraindication to LVAD therapy; however, they may impact the postoperative recovery phase, including mobility and wound healing. Prior to LVAD implant, patients must have all major comorbid conditions optimized for successful outcome. This includes but not limited to ensuring optimal end-organ function, glycemic control, elimination of infection, and mental readiness of both patient and caregiver. This chapter provides guidelines and considerations for optimization before LVAD implantation.]

Published: Nov 9, 2022

There are no references for this article.